FABP5 and cervical cancer: The mRNA and protein expression levels of FABP5 in cervical cancer (CCa) cells derived from lymph node metastatic sites (MS751) were significantly higher than those in CCa cells derived from primary sites (HeLa and SiHa) (Zhang et al., 2020).